"We are committed not only to the health, but also the overall well-being of our patients. Check our website for relevant links, patient testimonials, helpful information on coping with cancer, and more. No cancer treatment is 100% effective. For this reason, ongoing clinical research is an integral part of our approach to total patient care. For current up to date research studies please contact the office."

During the past decade, Hematology Oncology Associates of Illinois - Skokie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 73 clinical trials were completed, i.e. on average, 1216.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 21 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hematology Oncology Associates of Illinois - Skokie" #1 sponsor was "National Cancer Institute (NCI)" with 48 trials, followed by "Eastern Cooperative Oncology Group" with 24 trials sponsored, "SWOG Cancer Research Network" with 16 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored and "Alliance for Clinical Trials in Oncology" with 11 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology Oncology Associates of Illinois - Skokie" #1 collaborator was "National Cancer Institute (NCI)" with 60 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 9 trials as a collaborator and "Eastern Cooperative Oncology Group" with 5 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Hematology Oncology Associates of Illinois - Skokie" are "Breast Cancer" (12 trials), "Lymphoma" (9 trials), "Colorectal Cancer" (7 trials), "Leukemia" (6 trials) and "Recurrent Squamous Cell Lung Carcinoma" (6 trials). Many other conditions were trialed in "Hematology Oncology Associates of Illinois - Skokie" in a lesser frequency.

Most popular intervention types in "Hematology Oncology Associates of Illinois - Skokie" are "Drug" (109 trials), "Other" (55 trials), "Biological" (49 trials), "Procedure" (18 trials) and "Radiation" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (38 trials), "Bevacizumab" (13 trials), "Quality-of-Life Assessment" (10 trials), "Cyclophosphamide" (9 trials) and "Docetaxel" (9 trials). Other intervention names were less common.

The vast majority of trials in "Hematology Oncology Associates of Illinois - Skokie" are 107 trials for "All" genders, 12 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Hematology Oncology Associates of Illinois - Skokie". undefined are not yet recruiting, undefined are recruiting, 38 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 76 completed trials in Hematology Oncology Associates of Illinois - Skokie, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Hematology Oncology Associates of Illinois - Skokie, 2 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 65 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Hematology Oncology Associates of Illinois - Skokie has several departments that took part in Clinical trials: "North Shore Cancer Research Association" - 2 trials